FDA Orders 2 Companies To Stop Marketing Unapproved Nitroglycerin Tablets
March 18, 2010 – 1:21 amThe U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages. The FDA does not anticipate a supply problem for these products. Pfizer Inc. markets FDA-approved sublingual nitroglycerin tablets in the same strengths and is able to supply the market with approved products…
Related Info :
Tags: Chest Pain, Companies, Fda, Fda Approved, Food And Drug, Food And Drug Administration, Generics, Heart Attack, Konec Inc, Mahwah, Marketing, Nitroglycerin, Nitroglycerin Tablets, Orders, Pfizer, Pfizer Inc, Stop, Tablets, Tongue Pain, Tucson Ariz, Unapproved
2 Responses to “FDA Orders 2 Companies To Stop Marketing Unapproved Nitroglycerin Tablets”
i have just received from express scriptsa rx for nitro glycerin0.4mg made by glenmark.are they genric or on recall?
By charles melton on Sep 14, 2010
In the past few days I read a lot on the subject of social marketing. For me it is interesting how a topic can be so actual and everyone is talking about that .. To me it looks like a mass phenomenon as birds in flight or something like that. Evenmore I have a friend who has a theory saying that humans have some instinct for mass effects at one and the same time. Anyway. Let it be fun:)
By Affiliate Tools on Aug 24, 2011